"We May Have Struck Gold" Protein-altering Drug Reverses Memory and Learning Deficits in Down Syndrome Mouse Model

In a surprising finding using the standard animal model of Down syndrome (DS), scientists were able to correct the learning and memory deficits associated with the condition -- the leading genetic cause of cognitive disability and the most frequently diagnosed chromosomal disorder in the U.S. -- with drugs that target the body's response to cellular stresses.

Continue reading...